Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VERSAPEN-K

HETACILLIN POTASSIUM

Standard Dose
EQ 225MG AMPICIL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview VERSAPEN-K is listed in Drugs@FDA under application 061396 (ANDA).

Marketing status: Discontinued Active ingredient HETACILLIN POTASSIUM Form and strength CAPSULE;ORAL - EQ 225MG AMPICIL Sponsor BRISTOL Submission history Latest submission status date: 1971-03-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview VERSAPEN-K is listed in Drugs@FDA under application 061396 (ANDA). Marketing status: Discontinued Active ingredient HETACILLIN POTASSIUM Form and strength CAPSULE;ORAL - EQ 225MG AMPICIL Sponsor BRISTOL Submission history Latest submission status date: 1971-03-03 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
VERSAPEN-K (HETACILLIN POTASSIUM) | Drug Monograph | MedicHelpline